Tom Hughes

Tom Hughes has had an extensive and diverse work experience. Tom was the President & CEO of Navitor Pharmaceuticals from January 2020 to the present, and they previously served as the Chief Executive Officer from September 2018 to January 2020. At Totus Medicines, they are currently the Chairperson starting from May 2021. Tom is also an Independent Director at Constant Therapeutics starting from April 2023 and at Xeno Biosciences starting from March 2022. Additionally, Tom has been a Strategic Advisory Board Member at Broadview Ventures since June 2011 and a Scientific Advisory Board Member at FaunaBio since October 2018. From November 2020 to October 2022, they served as a Director (Board of Directors) at Deep Genomics. Tom also has experience as a Director (Board of Directors) at miRagen Therapeutics, Inc. from September 2009 to October 2020 and as the President and Chief Scientific Officer at Zafgen, Inc. from October 2017 to September 2018, and as the CEO from September 2008 to October 2017. Additionally, they were a Scientific Advisory Board Member at Nimbus Discovery from 2010 to 2016.

Tom Hughes completed their Bachelor of Arts degree in Biology from Franklin & Marshall College, where they studied from 1977 to 1981. Tom then pursued their Master of Science degree in Zoology at Virginia Tech from 1981 to 1984. Following this, they attended Tufts University from 1984 to 1987, where they obtained their PhD in Nutrition.